Steve E. Krognes, Director at Guardant Health, Inc. (GH), sold 6,674 shares at $174.46 ($1.2M) on 2026-09-16, disclosed to the SEC on 2026-09-17.
Seasonal sale ($1.2M) by Director — this insider has traded GH in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.46 | 1,103 | $192K | 16.4% |
| 2 | $175.42 | 3,300 | $579K | 49.4% |
| 3 | $176.34 | 1,300 | $229K | 19.5% |
| 4 | $177.48 | 971 | $172K | 14.7% |
| Total | $175.74 avg | 6,674 | $1.2M | 100% |
| Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |
| DNLI | SELL | 2024-08-22 | $41K | — | Filing → |